¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2019 ´ëÇÑÁ¶Ç÷¸ð¼¼À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (APBMT & ICBMT 2019) - 8¿ù 31ÀÏ : 2019-08-31

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2019 ´ëÇÑÁ¶Ç÷¸ð¼¼À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (APBMT & ICBMT 2019) - 8¿ù 31ÀÏ : 2019-08-31
±³À°ÀÏÀÚ : 2019-08-31
±³À°Àå¼Ò : º¤½ºÄÚ ROOM B  
±³À°ÁÖÁ¦ : 2019 ´ëÇÑÁ¶Ç÷¸ð¼¼À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (APBMT & ICBMT 2019) - 8¿ù 31ÀÏ
ÁÖÃÖ±â°ü : ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ
´ã´çÀÚ : ±èÈñÀç
¿¬¶ôó : 02-6711-4606  
À̸ÞÀÏ : apbmt.icbmt2019@gmail.com      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í Àü¹®ÀÇ 150,000¿ø Àü°øÀÇ/°£È£»ç/¿¬±¸¿ø/±âŸ 80,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-31 ROOM B 09:00~09:30 New directions in GVHD prophylaxis  Marie-Thérèse Rubiob(Chru Nancy France) 
±³À°½Ã°£ 08-31 ROOM B 09:30~10:00 New agents in GVHD treatment  Robert Zeiser(Univ. Hospital Freiburg Germany) 
±³À°½Ã°£ 08-31 ROOM B 10:00~10:30 Cancer immunotherapy in neuroblastoma  Alice L. Yu(Chang Gung University Taiwan) 
±³À°½Ã°£ 08-31 ROOM B 10:30~11:00 Update of high-risk neuroblastoma treatment  Ki Woong Sung(Sungskyunkwan University) 
±³À°½Ã°£ 08-31 ROOM B 11:00~11:30 The influence of microbiome on GVHD and relapse of primary disease  Van den Brin(MSKCC USA) 
±³À°½Ã°£ 08-31 ROOM B 11:30~12:00 FMT for refractory GVHD  Young-Seok Cho(The Catholic University of Korea) 
±³À°½Ã°£ 08-31 ROOM B 12:00~13:00 How to Improve Survival Rates for Patients Undergoing HSCT : Successful Management of VOD/SOS  Donal McLornan(Department of Haematological Medicine UK) 
±³À°½Ã°£ 08-31 ROOM B 13:00~13:30 HSCT in immune dysregulation syndromes: When and how?  Shanmuganathan Chandrakasan(Emory University USA) 
±³À°½Ã°£ 08-31 ROOM B 13:30~14:00 Unanswered questions in HSCT for primary immunodficiecny  Keon Hee Yoo(Sungkyunkwan University) 
±³À°½Ã°£ 08-31 ROOM B 14:00~14:30 Genome editing using CRISPR  Hyongbum Kim(Yonsei University) 
±³À°½Ã°£ 08-31 ROOM B 14:30~15:00 Clinical application of CRISPR-Cas system  Yongsub Kim(University of Ulsan) 
±³À°½Ã°£ 08-31 ROOM B 15:30~16:30 Impact of autologous stem cell transplantation on renal response in multiple myeloma patients with advanced renal failure  Joonyeop Lee(The Catholic University) 
±³À°½Ã°£ 08-31 ROOM B 16:30~17:30 Something Fun through Beer  SangJoon Pae(NHIS-Ilsan Hospital) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2019 ´ëÇÑÁ¶Ç÷¸ð¼¼À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (APBMT & ICBMT 2019) - 8¿ù 31ÀÏ : 2019-08-31""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŻý¾ÆÇÐȸ Á¦10Â÷ ±³À°¼¼¹Ì³ª ¥± : 2019-08-31
´ÙÀ½±Û ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ÀÓ»ó³úÆÄ ÇÏ°è ¿öÅ©¼ó : 2019-08-31
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20912 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 126 2024-05-28
20911 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 74 2024-05-28
20910 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 113 2024-05-28
20909 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 74 2024-05-28
20908 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 122 2024-05-28
20907 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 76 2024-05-28
20906 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 62 2024-05-28
20905 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 41 2024-05-28
20904 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 69 2024-05-28
20903 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 110 2024-05-28
20902 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 49 2024-05-28
20901 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 60 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 108 2024-05-28
20899 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 34 2024-05-28
20898 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 99 2024-05-28
21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷